Serial assessment of endothelial vasomotor function using optimal medical therapy predicts clinical outcomes in patients after complete coronary revascularization
暂无分享,去创建一个
[1] Takamitsu Nakamura,et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. , 2009, Journal of the American College of Cardiology.
[2] D. Celermajer,et al. Atherosclerosis-underlying inflammatory mechanisms and clinical implications. , 2008, The international journal of biochemistry & cell biology.
[3] E. Benjamin,et al. Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community , 2009, Circulation.
[4] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[5] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[6] E. Lonn,et al. Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) Study , 2011, Circulation.
[7] M. Rutter,et al. Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial. , 2015, Journal of the American College of Cardiology.
[8] J. Lekakis,et al. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. , 2006, The American journal of cardiology.
[9] M. Gawaz,et al. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. , 2008, European heart journal.
[10] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[11] David M. Herrington,et al. Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study: The Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.
[12] F. Hsu,et al. Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study , 2007, Circulation.
[13] S. Fichtlscherer,et al. Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.
[14] H. Fujita,et al. Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents. , 2016, The American journal of cardiology.
[15] M. Singer,et al. Inflammation and Endothelial Function: Direct Vascular Effects of Human C-Reactive Protein on Nitric Oxide Bioavailability , 2005, Circulation.
[16] Marco Valgimigli,et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.
[17] L. Lind,et al. Endothelial Function in Resistance and Conduit Arteries and 5-Year Risk of Cardiovascular Disease , 2011, Circulation.
[18] Tetsuya Takahashi,et al. Interactions among higher trait anxiety, sympathetic activity, and endothelial function in the elderly. , 2007, Journal of psychiatric research.
[19] C. Vlachopoulos,et al. Association of interleukin-18 levels with global arterial function and early structural changes in men without cardiovascular disease. , 2010, American journal of hypertension.
[20] H. Krumholz,et al. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2016, Journal of the American College of Cardiology.